MAID: An Ethical and Clinical Panel
Clinicians who treat eating disorders often struggle with the ethical and clinical considerations for clients with Severe and Enduring Eating Disorder (SEED) / Severe and Enduring Anorexia Nervosa (SEAN). This panel will explore the unique challenges facing clinicians, patients and care givers and discuss different perspectives related to medical aid in dying (MAID), including: the ability to make that decision, legal issues, ethical dilemmas, etc. Definitions of SEED, SEAN and terminal illness will be discussed. Additionally, the panel will seek to answer what constitutes criteria for MAID, a...Read mores well as what “exhausted treatment options” means in practice. Participants will leave the workshop with a better understanding of the steps to take (legal counsel, documentation, supervision, possible termination/HLOC referral, reporting, and self-care) if confronted with this situation. Join us for learning, support, and connection and take the first step towards improving your understanding and treatment of clients with severe and enduring eating disorders. Less...
Learning Objectives
- Define criteria of severe and enduring eating disorders and severe and enduring anorexia nervosa.
- Name 1 concrete step to take when treating a client with a case of SEAN who expresses desire to end their life.
- Identify 2 ethical issues that may arise when treating someone with SEAN/SEED.
Friday, September 22, 2023
10:30 AM EDT - 12:30 PM EDT
About the speakers
CE Information - Earn 2 CE Credit Hours
CE Approvals
National Board for Certified Counselors
Comission of Dietetic Registration
New York Education Department's State Board for Social Work
New York Education Department Board of Creative Arts Therapy
New York Education Department for Licensed Mental Health Counselors
New York State Education Department's State Board for Psychology
New York Education Department's State Board for Marriage and Family Therapy
CE Process Info
Each professional is responsible for the individual requirements as stipulated by his/her licensing agency. Please contact your individual licensing board/regulatory agency to review continuing education requirements for licensure renewal. Please note: You must attend "live" (in real-time) for the duration of the training to earn CE credits.
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ce-go.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ce-go.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:
PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.
FACULTY
Dr. <
Consultant - AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., GoodCap Pharmaceuticals, Inc., Senseye, Clexio, Ninnion Therapeutics, EmbarkNeuro, SynapseBio, BioXcel Therapeutics, Relmada Therapeutics
Ownership Interest - Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Naki Health, Relmada Therapeutics
Advisor - ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., Sage
Executive Role - Gratitude America, ADAA, Lucy Scientific Discovery, Inc.
Royalty Or Patent Beneficiary - Method and devices for transdermal delivery of lithium (US 6,375,990B1) Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)